Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

NCT04353869 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04353869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04353869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Completed
Start date
November 16, 2020
Completion date
January 10, 2024
Enrollment
995 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular complications, diabetic, glutamine